drugset / Trial / NCT04899908

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

NCT04899908

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether AGuIX (Activation and Guidance of Irradiation by X-ray) gadolinium-based nanoparticles make radiation work more effectively in the treatment of patients with brain metastases that are more difficult to control with stereotactic radiation alone.

Timeline

Start
2021-09-15
Primary completion
2028-04
Completion
2029-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AGuIX Other / unclassified 100 mg/kg Intravenous